Can early gene testing unlock better cancer treatments?

This study looks at whether doing broad gene testing early, instead of later, helps find more effective treatments for people with advanced pancreatic, liver, or triple-negative breast cancer. About 360 adults with poor-prognosis cancers will be randomly assigned to early or standard timing of gene testing. The goal is to see if early testing leads to more patients actually starting a treatment matched to their tumor's genetic profile.